Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.

Item
http://www.wikidata.org/entity/Q46002806
The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studiesThe risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cellsPersonalizing guidelines for diabetes management: twilight or dawn of the expert?Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studiesPrevalence and temporal pattern of hospital readmissions for patients with type I and type II diabetesThe role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes.Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.Is gliclazide a sulfonylurea with difference? A review in 2016.Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study.Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.Response to Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229.Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care.
P2860

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.

Item
http://www.wikidata.org/entity/Q46002806
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Sulfonylureas and prognosis af ...... ulation-based follow-up study.
@en
Sulfonylureas and prognosis af ...... ulation-based follow-up study.
@nl
type
label
Sulfonylureas and prognosis af ...... ulation-based follow-up study.
@en
Sulfonylureas and prognosis af ...... ulation-based follow-up study.
@nl
prefLabel
Sulfonylureas and prognosis af ...... ulation-based follow-up study.
@en
Sulfonylureas and prognosis af ...... ulation-based follow-up study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Sulfonylureas and prognosis af ...... ulation-based follow-up study.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921